Role of Glomerular Proteoglycans in IgA Nephropathy
Figure 6
Protein expression of perlecan in sections from control (A), a patient with IgAN (B), and a negative control (C).
Protein expression of Perlecan in frozen biopsy sections from another set of patients with IgAN stained significantly stronger for perlecan (n = 45, 6.3±0.7%) than controls (n = 30, 9.4±0.7%) P<0.01. Magnification ×63.